Concordant dyslipidemia, hypertension and early coronary disease in Utah families

R R Williams1, S C Hunt, L L Wu

  • 1Department of Medicine, University of Utah, Salt Lake City.

Klinische Wochenschrift
|January 1, 1990
PubMed

Insights

A new syndrome, familial dyslipidemic hypertension (FDH), was identified in nearly half of hypertensive families. This condition links inherited metabolic issues to early heart disease, obesity, and high insulin levels.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Metabolic Syndrome

Background:

  • Familial aggregation of hypertension and coronary artery disease (CAD) suggests a genetic component.
  • Understanding shared inherited metabolic abnormalities is crucial for early disease prediction and prevention.

Purpose of the Study:

  • To investigate concordant abnormalities in siblings with early-onset hypertension or CAD.
  • To identify and characterize novel genetic syndromes contributing to these conditions.

Main Methods:

  • Family history questionnaires from 35,000 Utah high school students.
  • Clinical and biochemical evaluations of siblings from identified sibships.
  • Analysis of lipid profiles, insulin levels, and anthropometric measurements.

Main Results:

  • Familial dyslipidemic hypertension (FDH) identified in 48% of hypertensive sibships, characterized by low HDL-C, high triglycerides, and high LDL-C.
  • FDH subjects exhibited elevated fasting insulin, obesity markers, and VLDL cholesterol/apolipoprotein B.
  • Coronary sibships showed familial combined hyperlipidemia (30-40%), FDH (15-45%), and low HDL-C (10%).

Conclusions:

  • Inherited metabolic abnormalities, including FDH, contribute to the co-aggregation of hyperinsulinemia, obesity, hypertension, and early CAD.
  • Lifestyle modifications and medical interventions may help manage or prevent these metabolic disorders.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...